# Self-Assessment Method for Statin Side-effects Or Nocebo

> **NCT02668016** · PHASE4 · COMPLETED · sponsor: **Imperial College London** · enrollment: 60 (actual)

## Conditions studied

- Adverse Effects
- Cardiovascular Diseases
- Hyperlipidemias

## Interventions

- **DRUG:** Atorvastatin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02668016
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02668016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02668016, "Self-Assessment Method for Statin Side-effects Or Nocebo". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02668016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
